Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects

To see complete record on, please visit this link

Id: NCT00700076

Organisation Name: Yale University

Overal Status: Completed

Start Date: January 22, 2008

Last Update: March 3, 2022

Lead Sponsor: Yale University

Brief Summary: Org 25935 is a new putative antipsychotic agent developed by N.V. Organon.The primary objective of this study is to investigate the effect of Org 25935 on ketamine-induced impairments in immediate recall.

  • Healthy

Total execution time in seconds: 0.78257393836975